Heron Therapeutics, Inc. (HRTX): Depreciation & Amortization
$2.31M
Year ended 2025-12-31
$2.13M
Trailing 12 months to 2026-06-30
-7.1%
3-year compound annual growth
-4.1%
5-year compound annual growth
+12.2%
10-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $2.31M | -7.1% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $2.49M | -14.0% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $2.90M | +0.3% | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | $2.89M | -4.4% | 2025-02-27, From 2022-01-01 |
| 2021-12-31 | $3.02M | +6.1% | 2023-03-29, From 2021-01-01 |
| 2020-12-31 | $2.85M | +39.3% | 2022-02-28, From 2020-01-01 |
| 2019-12-31 | $2.04M | +35.1% | 2022-02-28, From 2019-01-01 |
| 2018-12-31 | $1.51M | -1.2% | 2021-02-24, From 2018-01-01 |
| 2017-12-31 | $1.53M | +39.3% | 2020-03-02, From 2017-01-01 |
| 2016-12-31 | $1.10M | +49.7% | 2019-02-22, From 2016-01-01 |
| 2015-12-31 | $734.0K | +27.0% | 2018-02-27, From 2015-01-01 |
| 2014-12-31 | $578.0K | +73.6% | 2017-02-23, From 2014-01-01 |
| 2013-12-31 | $333.0K | +69.0% | 2016-02-19, From 2013-01-01 |
| 2012-12-31 | $197.0K | +10.1% | 2015-03-13, From 2012-01-01 |
| 2011-12-31 | $179.0K | -21.1% | 2014-03-07, From 2011-01-01 |
| 2010-12-31 | $227.0K | -36.2% | 2013-03-01, From 2010-01-01 |
| 2009-12-31 | $356.0K | n/a | 2012-03-26, From 2009-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Heron Therapeutics, Inc. (HRTX) | 2025-12-31 | $2.31M | -7.1% |
| Liquidia Corp (LQDA) | 2025-12-31 | $1.53M | -30.5% |
| Macrogenics Inc (MGNX) | 2025-12-31 | $7.17M | -4.9% |
| Elite Pharmaceuticals Inc (ELTP) | 2026-03-31 | $1.07M | -12.6% |
| Phathom Pharmaceuticals, Inc. (PHAT) | 2025-12-31 | $633.0K | -20.4% |
| Cryoport, Inc. (CYRX) | 2025-12-31 | $27.71M | -9.9% |
| Lifevantage Corp (LFVN) | 2026-06-30 | $2.77M | -12.1% |
| Lifecore Biomedical, Inc. (LFCR) | 2025-05-25 | $8.03M | +0.9% |
| Rhythm Pharmaceuticals, Inc. (RYTM) | 2025-12-31 | $500.0K | -28.6% |
Compare HRTX, LQDA, MGNX, ELTP side by side · Screen every company in Pharmaceutical Preparations ↗